Overview: Direct Bilirubin TestIntroduction: The Direct Bilirubin Test measures direct bilirubin to assess liver or bile duct issues, causing jaundice or abdominal pain. Aligned with 2023 AASLD guidelines, it uses spectrophotometry for high sensitivity, aiding in liver screening. This test is critical for guiding diagnosis, treatment, and improving outcomes in biochemistry for patients with suspected liver or bile duct disorders.
Other Names: Conjugated Bilirubin Assay, Liver Function Test.
FDA Status: Laboratory-developed test (LDT), meeting biochemistry standards for diagnostic accuracy.
Historical Milestone: Bilirubin testing began in the 1910s with chemical assays. Spectrophotometry emerged in the 1960s, and by the 2000s, automated analyzers improved accuracy for liver disease detection.
Purpose: Diagnoses liver or bile duct disorders, guides treatment, and monitors bilirubin levels in patients with jaundice or abdominal pain.
Test Parameters: 1. Bilirubin Direct
Pretest Condition: Fasting for 10-12 hours required to stabilize bilirubin levels. Collect serum or plasma after overnight fasting. Report symptoms like jaundice or abdominal pain, and list medications like ursodeoxycholic acid.
Specimen: 2-5 mL serum (SST) or 2-4 mL plasma (EDTA). Centrifuge within 1 hour. Transport in a biohazard bag within 8 hours.
Sample Stability at Room Temperature: 8 hours
Sample Stability at Refrigeration: 7 days
Sample Stability at Frozen: 6 months
Medical History: Document liver or bile duct symptoms, history of liver disease, or family history of hepatic disorders. Include current medications, especially those affecting liver function.
Consent: Written consent required, detailing the tests purpose, diagnostic implications, and potential need for liver treatment or imaging.
Procedural Considerations: Uses spectrophotometry to measure direct bilirubin levels. Results are available in 1-2 days, enabling rapid clinical decisions.
Factors Affecting Result Accuracy: Non-fasting samples or hemolysis may alter results. Improper storage can degrade samples.
Clinical Significance: Elevated direct bilirubin levels indicate liver or bile duct dysfunction, prompting treatment or imaging. Normal levels suggest stable liver function.
Specialist Consultation: Consult a hepatologist for result interpretation. A gastroenterologist referral is advised for bile duct obstruction cases.
Additional Supporting Tests: Total bilirubin test, liver function tests, or liver ultrasound to confirm liver or bile duct disorders.
Test Limitations: False positives may occur with hemolysis or cholestasis. Results require clinical correlation with liver imaging.
References: AASLD Liver Guidelines, 2023; Hepatology, Lindor KD, 2022.
